Results 131 to 140 of about 4,106,944 (201)

Expanding the frontier of CAR therapy: comparative insights into CAR-T, CAR-NK, CAR-M, and CAR-DC approaches

Annals of Hematology
Zhang, Yiling, Hu, Rong, Xie, Xiaoling, Li, Yuhua   +3 more
openaire   +2 more sources

Non-Viral Cytokine-Inducible SH2 Containing Protein Locus-Specific Integrated Fibroblast Activation Protein Alpha-Targeting Chimeric Antigen Receptor T Cells Achieve Potent Antitumor Efficacy in Glioblastoma. [PDF]

MedComm (2020)
Dong X, Sun Y, Guo Y, Wang J, Wang F, Wang Z, Li R, Xie F, Tan T, Cheng B, Huang R, Zhang S, Lin X, Guo Z, Wu H, Wu H, Zhang X, Xie G.   +17 more
europepmc   +1 more source

Metabolic engineering of SLC38A2 reprograms glutamine utilization and enhances CAR-macrophage antitumor function in solid tumors. [PDF]

Cancer Biol Med
Liu M, Chen Q, Zhang L, Zhou Y, Wen N, Jin J, Cai J, Su S, Li J, Zhao Q.   +9 more
europepmc   +1 more source

IL-12-secreting CAR-T cells reprogram the tumor microenvironment and improve efficacy against heterogeneous models of glioblastoma. [PDF]

J Immunother Cancer
Shen S, Mohan AA, Hotchkiss KM, Cook S, Patel K, Moelker E, Puviindran B, Gonzalez AT, Zaidi S, Spellicy S, Schwartz A, Suryadevara C, Wilkinson D, Ayasoufi K, Fecci PE, Sanchez-Perez L, Sampson J, Patel A.   +17 more
europepmc   +1 more source

MMP14 is a safe target of CAR-T therapy against liver cancer and metastasis. [PDF]

J Transl Med
Yu Y, Zou S, Fan J, Yang D, Liu N, Bai Z, Zhu Y, Li L, Cao D, Zhao X, Zou J.   +10 more
europepmc   +1 more source

EVOLUTION OF CAR LOGOS [PDF]

, 2008
Yel’nyakova, Ye.
core  

Earlier CAR-T: fewer cytopenias, bigger questions. [PDF]

Blood Adv
Boisclair S, Al-Homsi AS.
europepmc   +1 more source

Association of ciltacabtagene autoleucel with immune effector cell-associated enterocolitis: insights from a large national database. [PDF]

Blood Cancer J
Frey C, Etminan M, Cherniawsky H.
europepmc   +1 more source

Editorial: Innovations in development, translational research and manufacturing of CAR T cells. [PDF]

Front Immunol
Krones D, Koehl U, Negre H, Rafiq Q, Goldrick S, Hudecek M.   +5 more
europepmc   +1 more source